Santarus Inc (SNTS)

[surf1944]

5:20PM Santarus announces FDA approval of Schering-Plough HealthCare Products' ZEGERID OTC (SNTS) 4.29 +0.30 : Co announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.'s, New Drug Application for ZEGERID OTC Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter treatment of frequent heartburn. Schering-Plough and Merck & Co. merged on November 3, 2009.